title: Integrated Allergy and Asthma Prevention and Care: Report of the MeDALL/AIRWAYS ICPs Meeting at the Ministry of Health and Care Services, Oslo, Norway.
abstract: Allergic diseases and asthma are increasing in prevalence globally. They can start early in life and many persist. It is important to prevent, detect and control these diseases early on and throughout life, so as to promote active and healthy ageing. The translational activities of MeDALL (Mechanisms of the Development of Allergy; EU FP7) are of great importance and include the deployment of successful allergy programmes. The Finnish Allergy Plan is a prototype for the prevention and control of severe allergic diseases. It has been considered for deployment to Norway by the Ministry of Health and Care Services in the frame of AIRWAYS ICPs (Integrated Care Pathways for Airway Diseases), a programme of Action Plan B3 of the EIP on AHA (European Innovation Partnership on Active and Healthy Ageing). Deployment of the Finnish and Norwegian Plans will make use of the scaling-up strategy of the EIP on AHA in regions in the European Union, and the WHO GARD (Global Alliance against Chronic Respiratory Diseases) globally. The regional deployment in Norway serves as a model of a national plan for the use of the EIP on AHA scaling-up strategy in other regions.
authors.affiliation: Department of Paediatrics, Oslo University Hospital, University of Oslo, Oslo, Norway.
authors.forename: Karin C
authors.initials: KC
authors.lastname: Lødrup Carlsen
authors.forename: Tari
authors.initials: T
authors.lastname: Haahtela
authors.forename: Kai-Håkon
authors.initials: KH
authors.lastname: Carlsen
authors.forename: Anders
authors.initials: A
authors.lastname: Smith
authors.forename: Marianne
authors.initials: M
authors.lastname: Bjerke
authors.forename: Magnus
authors.initials: M
authors.lastname: Wickman
authors.forename: Thomas
authors.initials: T
authors.lastname: Keil
authors.forename: Stéphane
authors.initials: S
authors.lastname: Ballereau
authors.forename: Anna
authors.initials: A
authors.lastname: Bedbrook
authors.forename: Anna
authors.initials: A
authors.lastname: Bergström
authors.forename: Martijn C
authors.initials: MC
authors.lastname: Nawjin
authors.forename: Mariona
authors.initials: M
authors.lastname: Pinart
authors.forename: Ingebjørg
authors.initials: I
authors.lastname: Skrindo
authors.forename: Cheng J
authors.initials: CJ
authors.lastname: Xu
authors.forename: Giuseppe
authors.initials: G
authors.lastname: De Carlo
authors.forename: Josep M
authors.initials: JM
authors.lastname: Anto
authors.forename: Jean
authors.initials: J
authors.lastname: Bousquet
mesh_terms: D001249:Asthma / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D002908:Chronic Disease / Q000453:epidemiology*; D005062:European Union; D006291:Health Policy / Q000331:legislation & jurisprudence*; D006801:Humans; D009664:Norway / Q000453:epidemiology